C9orf50 and neoplasm: Collectively, the relatively tumor‐specific expression pattern, combined with the non‐essential nature of C9ORF50 in normal physiology, strongly suggests that targeted inhibition of this protein may represent a promising therapeutic strategy with inherently constrained potential deleterious effects.